A new monoclonal antibody, mAB 4A12, identifies a role for the glycosaminoglycan (GAG) binding domain of RANTES in the antiviral effect against HIV-1 and intracellular Ca2+ signaling

Journal of Experimental Medicine

Volumn 188, Issue 10, 1998, Pages 1917-1927

  Burns, Jennifer M ^a   Gallo, Robert C ^a   DeVico, Anthony L ^a   Lewis, George K ^a  

^a NONE

Author keywords

chemokines; Human immunodeficiency virus 1; Monoclonal antibody signaling antiviral effect

Indexed keywords

CALCIUM; CHEMOKINE; GLYCOSAMINOGLYCAN; MONOCLONAL ANTIBODY; RANTES;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CALCIUM MOBILIZATION; EPITOPE MAPPING; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIVIRAL AGENTS; BINDING SITES; CALCIUM; CELL LINE; EPITOPE MAPPING; FLOW CYTOMETRY; GLYCOSAMINOGLYCANS; GLYCOSIDE HYDROLASES; HIV-1; HUMANS; LYMPHOCYTES; MICE; MODELS, MOLECULAR; PROTEIN STRUCTURE, SECONDARY; RANTES; SEQUENCE HOMOLOGY, AMINO ACID; SERINE ENDOPEPTIDASES;

EID: 0032538826     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.188.10.1917     Document Type: Article

References (48)

1. Cocchi, F., A.L. DeVico, A. Garzino-Demo, S.K. Arya, R.C. Gallo, and P. Lusso. 1995. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science. 270:1811-1815.
2. Feng, Y., C.C. Broder, P.E. Kennedy, and E.A. Berger. 1996. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science. 272:872-877.
3. Dragic, T., V. Litwin, G.P. Allaway, S.R. Martin, Y.X. Huang, K.A. Nagashima, C. Cayanan, P.J. Maddon, R.A. Koup, J.P. Moore, and W.A. Paxton. 1996. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature. 381:667-673.
4. He, J., Y. Chen, M. Farzan, H. Choe, A. Ohagen, S. Gartner, J. Busciglio, X. Yang, W. Hofmann, W. Newman, et al. 1997. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature. 385:645-649.
5. Choe, H., M. Farzan, Y. Sun, N. Sullivan, B. Rollins, P.D. Ponath, L. Wu, C.R. Mackay, G. LaRosa, W. Newman, et al. 1996. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell. 85:1135-1148.
6. Alkhatib, G., C. Combadiere, C.C. Broder, Y. Feng, P.E. Kennedy, P.M. Murphy, and E.A. Berger. 1996. CC CKR5: a RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science. 272:1955-1958.
7. Deng, H., R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. Di Marzio, S. Marmon, R.E. Sutton, C.M. Hill, et al. 1996. Identification of a major co-receptor for primary isolates of HIV-1. Nature. 381:661-666.
8. Farzan, M., H. Choe, K.A. Martin, Y. Sun, M. Sidelko, C.R. Mackay, N.P. Gerard, J. Sodroski, and C. Gerard. 1997. HIV-1 entry and macrophage inflammatory protein-1β-mediated signaling are independent functions of the chemokine receptor CCR5. J. Biol. Chem. 272:6854-6857.
9. Alkhatib, G., S.S. Ahuja, D. Light, S. Mummidi, E.A. Berger, and S.K. Ahuja. 1997. CC chemokine receptor 5-mediated signaling and HIV-1 co-receptor activity share common structural determinants. Critical residues in the third extracellular loop support HIV-1 fusion. J. Biol. Chem. 272:19771-19776.
10. Alkhatib, G., E.A. Berger, P.M. Murphy, and J.E. Pease. 1997. Determinants of HIV-1 coreceptor function on CC chemokine receptor 3. Importance of both extracellular and transmembrane/cytoplasmic regions. J. Biol. Chem. 272: 20420-20426.
11. Frade, J.M.R., M. Llorente, M. Mellado, J. Alcami, J.C. Gutierrez-Ramos, A. Zaballos, G. Real, and A.C. Martinez. 1997. The amino-terminal domain of the CCR2 chemokine receptor acts as coreceptor for HIV-1 infection. J. Clin. Invest. 100:497-502.
12. Farzan, M., H. Choe, L. Vaca, K. Martin, Y. Sun, E. Desjardins, N. Ruffing, L. Wu, R. Wyatt, N. Gerard, et al. 1998. A tyrosine-rich region in the N terminus of CCR5 is important for human immunodeficiency virus type 1 entry and mediates an association between gp120 and CCR5. J. Virol. 72:1160-1164.
13. Dragic, T., A. Trkola, S.W. Lin, K.A. Nagashima, F. Kajumo, L. Zhao, W.C. Olson, L. Wu, C.R. Mackay, G.P. Allaway, et al. 1998. Amino-terminal substitutions in the CCR5 coreceptor impair gp120 binding and human immunodeficiency virus type 1 entry. J. Virol. 72:279-285.
14. Picard, L., G. Simmons, C.A. Power, A. Meyer, R.A. Weiss, and P.R. Clapham. 1997. Multiple extracellular domains of CCR-5 contribute to human immunodeficiency virus type 1 entry and fusion. J. Virol. 71:5003-5011.
15. Kuhmann, S.E., E.J. Platt, S.L. Kozak, and D. Kabat. 1997. Polymorphisms in the CCR5 genes of African green monkeys and mice implicate specific amino acids in infections by simian and human immunodeficiency viruses. J. Virol. 71: 8642-8656.
16. Benkirane, M., D.Y. Jin, R.F. Chun, R.A. Koup, and K.T. Jeang. 1997. Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5Δ32. J. Biol. Chem. 272:30603-30606.
17. Samson, M., G. LaRosa, F. Libert, P. Paindavoine, M. Detheux, G. Vassart, and M. Parmentier. 1997. The second extracellular loop of CCR5 is the major determinant of ligand specificity. J. Biol. Chem. 272:24934-24941.
18. Wu, L., G. LaRosa, N. Kassam, C.J. Gordon, H. Heath, N. Ruffing, H. Chen, J. Humblias, M. Samson, M. Parmentier, et al. 1997. Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding. J. Exp. Med. 186: 1373-1381.
19. Ross, T.M., P.D. Bieniasz, and B.R. Cullen. 1998. Multiple residues contribute to the inability of murine CCR-5 to function as a coreceptor for macrophage-tropic human immunodeficiency virus type 1 isolates. J. Virol. 72:1918-1924.
20. Brelot, A., N. Heveker, O. Pleskoff, N. Sol, and M. Alizon. 1997. Role of the first and third extracellular domains of CXCR-4 in human immunodeficiency virus coreceptor activity. J Virol. 71:4744-4751.
21. Picard, L., D.A. Wilkinson, A. McKnight, P.W. Gray, J.A. Hoxie, P.R. Clapham, and R.A. Weiss. 1997. Role of the amino-terminal extracellular domain of CXCR-4 in human immunodeficiency virus type 1 entry. Virology. 231:105-111.
22. Doranz, B.J., Z.H. Lu, J. Rucker, T.Y. Zhang, M. Sharron, Y.H. Cen, Z.X. Wang, H.H. Guo, J.G. Du, M.A. Accavitti, et al. 1997. Two distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1. J. Virol. 71:6305-6314.
23. Gosling, J., F.S. Monteclaro, R.E. Atchison, H. Arai, C.L. Tsou, M.A. Goldsmith, and I.F. Charo. 1997. Molecular uncoupling of C-C chemokine receptor 5-induced chemotaxis and signal transduction from HIV-1 coreceptor activity. Proc. Natl. Acad. Sci. USA. 94:5061-5066.
24. Atchison, R.E., J. Gosling, F.S. Monteclaro, C. Franci, L. Digilio, I.F. Charo, and M.A. Goldsmith. 1996. Multiple extracellular elements of CCR5 and HIV-1 entry: dissociation from response to chemokines. Science. 274:1924-1926.
25. Cocchi, F., A.L. DeVico, A. Garzino-Demo, A. Cara, R.C. Gallo, and P. Lusso. 1996. The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection. Nat. Med. 2:1244-1247.
26. Alkhatib, G., M. Locati, P.E. Kennedy, P.M. Murphy, and E.A. Berger. 1997. HIV-1 coreceptor activity of CCR5 and its inhibition by chemokines: independence from G protein signaling and importance of coreceptor downmodulation. Virology. 234:340-348.
27. Oravecz, T., M. Pall, J. Wang, G. Roderiquez, M. Ditto, and M.A. Norcross. 1997. Regulation of anti-HIV-1 activity of RANTES by heparan sulfate proteoglycans. J. Immunol. 159: 4587-4592.
28. Wagner, L., O.O. Yang, E.A. Garcia-Zepeda, Y. Ge, S.A. Kalams, B.D. Walker, M.S. Pasternack, and A.D. Luster. 1998. Beta-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans. Nature. 391:908-911.
29. Hornbeck, P.V., and G.K. Lewis. 1983. Idiotype connectance in the immune system. I. Expression of a cross-reactive idiotype on induced anti-p-azophenylarsonate antibodies and on endogenous antibodies not specific for arsonate. J. Exp. Med. 157:1116-1136.
30. Evan, G.I., G.K. Lewis, G. Ramsay, and J.M. Bishop. 1985. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol. Cell. Biol. 5:3610-3616.
31. Hornbeck, P.V., and G.K. Lewis. 1985. Idiotype connectance in the immune system. II. A heavy chain variable region idiotope that dominates the antibody response to the p-azobenzenearsonate group is a minor idiotope in the response to trinitrophenyl group. J. Exp. Med. 161:53-71.
32. Monta, C.T., W.L. Godfrey, J.W. Goodman, and G.K. Lewis. 1986. Arsonate-specific murine T cell clones. III. Correlation between clonotype expression and fine specificity for analogs of L-tyrosine-p-azobenzenearsonate. J. Immunol. 137:2139-2144.
33. Abacioglu, Y.H., T.R. Fouts, J.D. Laman, E. Claassen, S.H. Pincus, J.P. Moore, C.A. Roby, R. Kamin-Lewis, and G.K. Lewis. 1994. Epitope mapping and topology of baculovirus-expressed HIV-1 gp160 determined with a panel of murine monoclonal antibodies. AIDS Res. Hum. Retroviruses. 10: 371-381.
34. Burns, J.M., and G.K. Lewis. 1997. Improved measurement of calcium mobilization by flow cytometry. Biotechniques. 23: 1022-1024, 1026.
35. Pal, R., A. Garzino-Demo, P.D. Markham, J. Burns, M. Brown, R.C. Gallo, and A.L. DeVico. 1997. Inhibition of HIV-1 infection by the beta-chemokine MDC. Science. 278: 695-698.
36. Devico, A.L., R. Rahman, M.G. Sarngadharan, and F.D. Veronese. 1994. Mechanism of enzyme inhibition mediated by anti-reverse transcriptase antibodies from HIV type 1-infected individuals. AIDS Res. Hum. Retroviruses. 10:953-960.
37. Maione, T.E., G.S. Gray, A.J. Hunt, and R.J. Sharpe. 1991. Inhibition of tumor growth in mice by an analogue of platelet factor 4 that lacks affinity for heparin and retains potent angiostatic activity. Cancer Res. 51:2077-2083.
38. Webb, L.M., M.U. Ehrengruber, I. Clark-Lewis, M. Baggiolini, and A. Rot. 1993. Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8. Proc. Natl. Acad. Sci. USA. 90:7158-7162.
39. Witt, D.P., and A.D. Lander. 1994. Differential binding of chemokines to glycosaminoglycan subpopulations. Curr. Biol. 4:394-400.
40. Koopmann, W., and M.S. Krangel. 1997. Identification of a glycosaminoglycan-binding site in chemokine macrophage inflammatory protein-1alpha. J. Biol. Chem. 272:10103-10109.
41. Hoogewerf, A.J., G.S. Kuschert, A.E. Proudfoot, F. Borlat, I. Claric-Lewis, C.A. Power, and T.N. Wells. 1997. Glycosammoglycans mediate cell surface oligomerization of chemokines. Biochemistry. 36:13570-13578.
42. Lusso, P., F. Cocchi, C. Balotta, P.D. Markham, A. Louie, P. Farci, R. Pal, R.C. Gallo, and M.S. Reitz, Jr. 1995. Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1 J. Virol. 69:3712-3720.
43. Utsunomiya, I., K. Tani, W. Gong, J.J. Oppenheim, and J.M. Wang. 1997. Differential expression of binding sites for chemokine RANTES on human T lymphocytes. Eur. J. Immunol. 27:1406-1412.
44. Jackson, R.L., S.J. Busch, and A.D. Cardin. 1991. Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes. Physiol. Rev. 71:481-539.
45. Bacon, K.B., B.A. Premack, P. Gardner, and T.J. Schall. 1995. Activation of dual T cell signaling pathways by the chemokine RANTES. Science. 269:1727-1730.
46. Pakianathan, D.R., E.G. Kuta, D.R. Artis, N.J. Skelton, and C.A. Hebert. 1997. Distinct but overlapping epitopes for the interaction of a CC-chemokine with CCR1, CCR3 and CCR5. Biochemistry. 36:9642-9648.
47. Graham, G.J., P.C. Wilkinson, R.J. Nibbs, S. Lowe, S.O. Kolset, A. Parker, M.G. Freshney, M.L. Tsang, and I.B. Pragnell. 1996. Uncoupling of stem cell inhibition from monocyte chemoattraction in MIP-1α by mutagenesis of the proteoglycan binding site. EMBO (Eur. Mol. Biol. Organ.) J. 15:6506-6515.
48. Skelton, N.J., F. Aspiras, J. Ogez, and T.J. Schall. 1995. Proton NMR assignments and solution conformation of RANTES, a chemokine of the C-C type. Biochemistry. 34: 5329-5342.